polatuzumab vedotin
Term · Oncology and biomedicine · MLC-T-ONC-006782
A drug used with other drugs to treat adults with certain types of diffuse large B-cell lymphoma. It is also being studied in the treatment of other types of cancer. Polatuzumab vedotin contains a monoclonal antibody that binds to a protein called CD79B, which is found on B cells (a type of white blood cell) and some lymphoma cells. It also contains an anticancer drug, which may help kill cancer cells. Polatuzumab vedotin is a type of antibody-drug conjugate. Also called Polivy.
| Identifier | MLC-T-ONC-006782 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Polivy |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006782",
"term": "polatuzumab vedotin",
"field": "Oncology and biomedicine",
"definition": "A drug used with other drugs to treat adults with certain types of diffuse large B-cell lymphoma. It is also being studied in the treatment of other types of cancer. Polatuzumab vedotin contains a monoclonal antibody that binds to a protein called CD79B, which is found on B cells (a type of white blood cell) and some lymphoma cells. It also contains an anticancer drug, which may help kill cancer cells. Polatuzumab vedotin is a type of antibody-drug conjugate. Also called Polivy.",
"synonyms": [
"Polivy"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/polatuzumab-vedotin/"
}
Record 13,409 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.